Tony Butler
Stock Analyst at Rodman & Renshaw
(0.98)
# 3,526
Out of 4,829 analysts
105
Total ratings
31.37%
Success rate
-13.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $7.31 | +242.00% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $3.99 | +175.69% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.63 | +1,004.29% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $2.63 | +470.34% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.34 | +2,288.06% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.54 | +2,879.52% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.29 | +3,317.64% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.04 | +861.54% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $35.62 | +110.56% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $40.90 | -14.43% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $2.32 | +2,486.21% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.26 | +931.75% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $8.34 | +499.52% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.16 | +1,193.10% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.43 | +5,716.66% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.07 | +1,301.87% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.25 | +3,951.86% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $2.00 | +750.00% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $2.91 | +5,604.47% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $7.71 | +678.21% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.16 | +4,982.59% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.50 | +1,100.00% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $6.18 | +5,725.24% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $6.90 | -71.01% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $4.34 | +245.62% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.17 | +754.70% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.82 | +724.18% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $8.12 | +1,254.68% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.45 | +17,837.22% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $7.31
Upside: +242.00%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $3.99
Upside: +175.69%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.63
Upside: +1,004.29%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.63
Upside: +470.34%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.34
Upside: +2,288.06%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.54
Upside: +2,879.52%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.29
Upside: +3,317.64%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.04
Upside: +861.54%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $35.62
Upside: +110.56%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $40.90
Upside: -14.43%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $2.32
Upside: +2,486.21%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.26
Upside: +931.75%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $8.34
Upside: +499.52%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.16
Upside: +1,193.10%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.43
Upside: +5,716.66%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.07
Upside: +1,301.87%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $0.25
Upside: +3,951.86%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $2.00
Upside: +750.00%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $2.91
Upside: +5,604.47%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $7.71
Upside: +678.21%
Jun 5, 2023
Reiterates: Buy
Price Target: $8
Current: $0.16
Upside: +4,982.59%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.50
Upside: +1,100.00%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $6.18
Upside: +5,725.24%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $6.90
Upside: -71.01%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $4.34
Upside: +245.62%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.17
Upside: +754.70%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $1.82
Upside: +724.18%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $8.12
Upside: +1,254.68%
Mar 2, 2020
Initiates: Buy
Price Target: $80
Current: $0.45
Upside: +17,837.22%